leisure time -WSS

leisure time

author：leisure time 2025-08-12 09:12:51 - browse：898

Ethylene Oxide Sterilizer machine. -- health tech coverage from STAT — Ethylene oxide, a chemical used to sterilize half of all medical devices in the U.S., can also cause cancer. 3M via AP

The chemical used to sterilize half of all medical devices in the United States is also known to cause cancer. After years of deliberating on alternatives, the Food and Drug Administration this month deemed a safer gas, vaporized hydrogen peroxide, a legitimate way to decontaminate devices.

It’s a small step in pushing the medical device industry away from the carcinogenic chemical, called ethylene oxide. The move comes as the Environmental Protection Agency prepares to finalize restrictions on ethylene oxide in March. Medical device manufacturers will have 18 months to comply.

Environmental activists organizing against the sterilizing facilities in their communities commend the EPA for curtailing the chemical. But they also want the FDA to more adamantly push device makers toward alternatives, which the FDA’s endorsement does not do.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Wegovy, Zepbound and weight loss drugs that preserve muscle

focus

WSS

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Astellas still sees hope in its gene therapy after four deaths

Wegovy, Zepbound and weight loss drugs that preserve muscle

Morphosys mixed study results for blood cancer drug

Does good food count as health care? Study aims to find out

Ransomware attacks on hospitals: Study outlines patient impact

focus

leisure time

hotspot

Affirmative action in medical school literally saved lives

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Sports medicine is finally prioritizing gender equality

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Heart attack and stroke risk calculators need revising

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

The cancer drug shortage isn’t new — and neither are the solutions

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

State Dept. review finds Biden bears some blame for Afghanistan failures

Morphosys mixed study results for blood cancer drug

focus

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Morphosys mixed study results for blood cancer drug

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Gain of function research would be limited under House proposal

knowledge

focus

Wikipedia

focus